|
⚲
|
| Keyboard |
| Grantham Mayo van Otterloo & Co LLC
✚
|
|
|---|---|
| CRD # | 106220 |
| SEC # | 801-15028 |
| CIK # | 0001352662 |
| AUM | 80.97 B (2026-05-11) |
| Employees | 365 (25% Investors, 12% Brokers) |
| Fees | |
| Minimum | |
| Phone | 617-330-7500 |
| Address | 53 State Street Boston, MA 02109 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5. Fees and Compensation A. The rate of GMO’s advisory (or management) or service fee varies with the type of service, product or asset class being managed, the investment strategy being employed, and the vehicle type in which the strategy is being implemented. GMO’s fees are generally asset-based and calculated at an annual rate as a percentage of the value of the net assets in the account. In some cases, GMO is paid a combination of an asset-based fee and a performance fee. The performance fee may take the form of a special allocation of profit to GMO, or an affiliate, from a GMO pooled vehicle. Special allocations and performance-based fees or performance fees are referred to interchangeably throughout this brochure. The performance fee may be calculated in a variety of ways depending on multiple factors including, but not limited to, the nature of the strategy, relevant performance benchmarks and performance hurdles, and is generally calculated based on both realized and unrealized amounts. Please see Item 6, “Performance-Based Fees and Side-by-Side Management” for more information. Under appropriate circumstances, in GMO’s discretion and where permitted by applicable law, the terms of an investment advisory contract, including fee schedules, terms of payment and termination provisions, may be negotiable. The asset-based fees paid to GMO by clients with discretionary separately managed accounts generally range from 0.18% to 1.00%. The asset- based management fee rate for a separately managed account will typically begin at a higher rate than a pooled investment vehicle managed in the same strategy. With respect to accounts in the Manager Advised Separate Account program, GMO agrees on the advisory fee payable with the client’s wealth advisor. As stated above, for those accounts, an independent wealth advisor selects an investment strategy on behalf of a client, and the wealth advisor and/or the wealth advisor’s client enters into an agreement with GMO for GMO to provide sub-advisory services to the client’s account. The advisory fees payable for a Manager Advised Separate Account may change based on certain factors, including the aggregate amount of assets (i) in client accounts that belong to the same household or (ii) the wealth advisor’s clients, or clients of the wealth advisor’s service providers, have invested in GMO funds or strategies, including the Manager Advised Separate Accounts. Advisory fees for clients in Manager Advised Separate Accounts can differ as a result of the client’s wealth advisor and the wealth advisor’s relationship with GMO. These fees may also be payable in advance. GMO may, for fee calculation purposes, agree to aggregate the assets of related accounts that are being managed for the same client even if such account(s) is/are managed by an affiliate of GMO. In those circumstances, the aggregate accounts may receive the benefit of a lower effective fee due to the combined level of assets. Certain clients from time to time seek to include most favored nation (“MFN” and such client an “MFN Client”) clauses in their investment management agreements with GMO. GMO considers agreeing to an MFN clause in view of a number of factors, which may include the client’s overall relationship with GMO. These clauses generally require GMO to notify the MFN Client if GMO has entered into, or subsequently enters into, a more favorable fee arrangement with a comparable client and offer the MFN Client the same fee arrangement or notify the MFN Client of such fee arrangement. Whether an account will be considered comparable will depend upon the language of the client’s agreement with GMO. The agreement may provide for consideration of factors including, but not limited to, the size of the account, scope and type of relationships with GMO, restrictions on account, level of services required for the account, investment strategy, investment objectives and discretionary character of the account. GMO does not agree to MFN clauses in all circumstances and has sole discretion over whether to grant an MFN clause. The GMO Trust mutual funds (each a “GMO Trust Fund” and collectively, “GMO Trust Funds”) pay, directly or indirectly, management, service, and/or supplemental support fees to GMO. The total net annual expenses of the GMO Trust Funds generally range from 0.02% to 2.50%. Total net annual expenses are charged to and deducted from the GMO Trust Funds in arrears. Additional information on each GMO Trust Fund’s fees and expenses is provided in the respective prospectuses, as supplemented and/or amended from time to time. In consideration for the services GMO provides to each series of GMO ETF Trust (each, a “GMO ETF”) and for GMO’s agreement to pay all of the expenses incurred by the relevant GMO ETF (with certain exceptions), GMO is paid an investment advisory fee based on the average daily assets of the GMO ETF. The investment advisory fees for the GMO ETFs generally range from 0.20% to 0.65%. Additional information on each GMO ETF’s fees and expenses is provided in the respective prospectuses, as supplemented and/or amended from time to time. The stated asset-based fee rates for each private pooled product advised by GMO, excluding GMO Trust Funds and GMO ETFs (collectively, the “GMO Private Funds”), are set forth in detail in each GMO Private Fund’s offering documentation. Note that the universe of GMO Private Funds contemplated in this brochure may be broader than the list of “private funds” required to be reported in Item 7.B of Part 1A of Form ADV, and that GMO-managed UCITS and qualifying investment funds domiciled in Ireland are not “investment companies” within the Investment Company Act of 1940, as amended, by virtue of Sections 3(c)(1) and/or 3(c)(7) and are included within the defined term “GMO Private Funds” for purposes of this brochure. ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7. Types of Clients GMO provides investment advice to a wide variety of clients, including, but not limited to, endowments, foundations; employee benefit, pension and contribution plans; governmental and supranational entities; family offices; high net worth individuals; taxable entities; investment companies; pooled investment vehicles; trusts; other institutions (including financial intermediaries) and individuals (including individual retirement accounts). The minimum account size for investment in certain share classes of the GMO Trust Funds varies but generally requires at least a $1 million commitment. For the GMO Private Funds, the minimum account size varies depending on the vehicle, but is generally at least $1 million and there are generally legal and/or regulatory based limitations on the types of eligible investors. Minimum account size requirements are waived for Members and employees and for other investors at GMO’s discretion including, without limitation, intermediaries. GMO may waive a GMO Fund’s investment minimum for certain clients in certain circumstances (e.g., for clients whose investment consultant has full discretion or exercises substantial influence over its clients’ assets and where the relationship meets the investment minimum). The minimum account size for separately managed accounts varies by investment strategy. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Microsoft Corp | 2.3 | ||
| Alphabet Inc | 2.0 | ||
| Johnson & Johnson | 1.8 | ||
| Apple Inc | 1.8 | ||
| Facebook Inc | 1.8 | ||
| Lam Research Corp | 1.5 | ||
| Amazon Com Inc | 1.3 | ||
| Thermo Fisher Scientific Inc | 1.2 | ||
| Broadcom Inc | 1.0 | ||
| US Bancorp de | 1.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Gmo-Usonian Special Situations Fund II LP | 2026-03-31 | ||
| HF | GMO World Market Neutral Fund Feeder LP | 2025-06-30 | 43.4 M | |
| HF | GMO World Market Neutral Fund LP | [2025-06-30] | 85.0 M | 124.5 M |
| Filed 2025-06-20 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Manatee Cove Partners EMD Fund LP | 2025-06-30 | 355.6 M | |
| HF | GMO Capital Investment Solutions Fund LP | [2025-03-28] | 350.3 M | 798.8 M |
| Filed 2025-05-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | GMO Capital Investment Solutions Fund Offshore LP | 2025-03-28 | ||
| HF | GMO Horizons Investment Fund | 2024-03-28 | 23.6 M | |
| HF | GMO US Quality Investment Fund | 2024-03-28 | ||
| HF | GMO Quality Select Investment Fund | 2023-10-17 | 356.3 M | |
| HF | Usonian Dedicated Investments LP | 2023-03-29 | 82.2 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 40 | 19.1 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 53 | 25.2 |
| (g) Pension and profit sharing plans | 15 | 7.1 |
| (h) Charitable organizations | 16 | 7.6 |
| (i) State or municipal government entities | 9 | 4.3 |
| (j) Other investment advisers | 7 | 3.3 |
| (k) Insurance companies | 1 | 0.5 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 13 | 6.2 |
| (n) Other | 16 | 7.6 |
| Total | 170 | 81.0 |
| By Discretionary | ||
| Discretionary | 161 | 79.4 |
| Non-Discretionary | 9 | 1.6 |
| Total | 170 | 81.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 31.2 | |
| United States Persons | 49.7 | |
| Total | 170 | 81.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Dawn Griffiths | Director | 74 | 14 | |
| Thomas Smith | Director | 100 | 8 | |
| Eimear Cowhey | Director | 21 | 7 | |
| Kevin O'Brien | Executive Officer | 76 | 4 | |
| Christopher Crawshaw | Executive Officer | 21 | 4 | |
| David Bohan | Director, Executive Officer | 53 | 3 | |
| Thomas Cooper | Director | 48 | 3 | |
| John Fitzpatrick | Director | 16 | 3 | |
| Laura Moret | Executive Officer | 15 | 3 | |
| Susan Steiner | Executive Officer | 14 | 3 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001352662] | |
| SC 13G | [0001352662] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $96.7B |
| Serves | Institutional, Retail, Research |
| Fund Types | Hedge Fund, Private Equity |
| LEI | KG0ECHUB6SFORDPJZK65 |
| Related Firms | State | AUM |
|---|---|---|
|
Grantham Mayo van Otterloo & Co LLC
✚
|
MA | 80.97 B |
|
GMO Europe LLC
✚
|
MA |
| Comparable Firms | State | AUM |
|---|---|---|
|
Mackay Shields LLC
✚
|
NY | 159.52 B |
|
Wilshire Advisors LLC
✚
|
CA | 149.10 B |
|
MIO Partners Inc
✚
|
NY | 59.59 B |
|
LIDO Advisors LLC
✚
|
CA | 42.50 B |
|
Oppenheimer Asset Management Inc
✚
|
NY | 21.33 B |
|
Horizon Kinetics Asset Management LLC
✚
|
NY | 9,614.0 M |
|
Stelac Advisory Services LLC
✚
|
NY | 6,286.4 M |
|
B Riley Wealth Advisors Inc
✚
|
TN | 4,211.6 M |
|
Palisade Capital Management LP
✚
|
NJ | 3,862.5 M |
|
CM Wealth Advisors LLC
✚
|
OH | 3,597.4 M |